Analysis of De-identified Data From Commercially-available App Lose It!

September 28, 2022 updated by: Johns Hopkins Bloomberg School of Public Health
The study team analyzed de-identified user data provided by the commercial app Lose It!, an entity of FitNow, Inc.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

The study team analyzed de-identified user data collected by Lose It! for the purposes of investigating behavioral aspects of weight loss and maintenance, including engagement with the platform; user-reported data on diet, exercise, and other behaviors; data generated by Lose It! describing macronutrient or total calorie intake; periodicity of weight-related actions; user-reported demographic information; and any data from linked applications within Lose It!. All data was anonymized and exchanged as limited data sets.

Study Type

Observational

Enrollment (Actual)

7007

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 80 years (Adult, Older Adult)

Accepts Healthy Volunteers

N/A

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

New app users located in the U.S. and Canada, between 18 and 80 years of age, that are overweight (25 < BMI < 30) or obese (BMI > 30), who actively used the app each month from January to May of 2016, defined as users who logged food at least 8 times during the first or second half of each month (January, February, March, April and May).

Description

Inclusion Criteria:

- New app users located in the U.S. and Canada, between 18 and 80 years of age, that are overweight (25 < BMI < 30) or obese (BMI > 30), who actively used the app each month from January to May of 2016, defined as users who logged food at least 8 times during the first or second half of each month (January, February, March, April and May).

Exclusion Criteria:

-

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Percent body weight lost
Time Frame: five months
Percent body weight lost over first five months of 2016
five months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Johns Hopkins Bloomberg School of Public Health

Collaborators

FitNow Inc

Investigators

  • Principal Investigator: Lawrence Cheskin, MD, Johns Hopkins Bloomberg School of Public Health

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

May 1, 2016

Primary Completion (Actual)

May 1, 2018

Study Completion (Actual)

December 1, 2018

Study Registration Dates

First Submitted

April 28, 2017

First Submitted That Met QC Criteria

April 28, 2017

First Posted (Actual)

May 2, 2017

Study Record Updates

Last Update Posted (Actual)

October 3, 2022

Last Update Submitted That Met QC Criteria

September 28, 2022

Last Verified

September 1, 2022

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • Lose It! data analysis

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Overweight and Obesity

Clinical Trials on Lose It! commercial weight loss app

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in China

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

3
Subscribe